The global sales of low frequency ultrasound are estimated to be worth USD 1,239.1 million in 2025 and are anticipated to reach a value of USD 2,065.1 million by 2035. Sales are projected to rise at a CAGR of 5.2% over the forecast period between 2025 and 2035. The revenue generated by low frequency ultrasound in 2024 was USD 1,184.6 million.
The Low Frequency Ultrasound market is experiencing rapid growth due to the increase in demand for non-invasive therapeutic solutions, development in ultrasound technology, and increase in preventive healthcare awareness. These devices are widely utilized for various applications including musculoskeletal rehabilitation, pain management, tissue healing, and wound care rendering them very popular with clinical.
The portability of ultrasound devices is a major factor in enhancing market growth which allows patients to manage effective treatments with less hospital visits. These technological innovations have been instrumental in improving accessibility, affordability, and effectiveness of these devices thus contributing to the growth of marketplace in finding convenient healthcare options.
Global Low Frequency Ultrasound Industry Assessment
| Attributes | Key Insights |
|---|---|
| Historical Size, 2024 | USD 1,184.6 million |
| Estimated Size, 2025 | USD 1,239.1 million |
| Projected Size, 2035 | USD 2,065.1 million |
| Value-based CAGR (2025 to 2035) | 5.2% |
The creation of multifunctional ultrasound machines is on the rise within low-frequency ultrasound markets, with increasing demand for more adaptable and price-friendly solutions in health care. Advanced ultrasound systems are thereby designed to serve two functions-diagnostic and therapeutic-in a manner that does no violence to the continued services of providers in treating patients.
The technological advancement of diagnostic and therapeutic capabilities into one unit allows for the reduction in the number of machines necessary.
These multifunctional devices find manifold applications in the areas of musculoskeletal medicine, rehabilitation, and physical therapy, such as diagnostic imaging in musculoskeletal injuries or pathologies and therapeutic treatment for pain relief, increased tissue healing, and reduced inflammation via ultrasound therapy.
Such dual-purpose technology certainly can tick all the checkboxes of clinics, hospitals, and rehabilitation centers regarding efficiency and cost-cutting measures.
Training of medical personnel is made easier as both diagnostic and therapeutic functions are integrated into one system, which reduces the learning curve occasioned by the operation of various specialized devices. That way, healthcare providers can provide more comprehensive care without having to invest in other separate pieces of technology.
Also promotes growth in the development of ultrasound devices in developing markets characterized by high demand for affordable and multi-purpose solutions at the same time.
Besides, the further improvement of the functional characteristics of these multichain ultrasound systems is likely to become one of the main methods of non-invasive investigations in the next few years.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Rising Prevalence of Musculoskeletal Disorders Driving Market Growth
Low-frequency ultrasound devices are an effective tool for the treatment for musculoskeletal disorders, providing non-invasive pain relief. There has been an increasing disease burden of musculoskeletal disorders across worldwide. Patient with chronic musculoskeletal disorders prefers non-invasive treatment over drug therapy.
Low-frequency ultrasound operates through sound waves interacting with tissues, assisting blood circulation and relaxation of muscles to reduce inflammation. This mechanism of therapy promotes the healing of tissues and significantly reduces the healing time for the injuries and therefore is increasingly being used for treating musculoskeletal pains.
Low-frequency ultrasound devices especially manage the symptoms of osteoarthritis and tendonitis whose pain could afford some degree of relief, and the joint active would benefit from enhanced function. Used also in physical therapy, the devices have quite proudly made their credit through providing treatment to muscle sprints and strains, through post-operative rehabilitation cases.
Moreover, the use of ultrasound also targets localized areas with exactness, thus making pain management quite effective with neither invasive procedures nor reliance upon medications and therefore, potentially could be an attractive choice to the patients who would want treatment without medication.
As such, the incidence of musculoskeletal disorders requirement growing low-frequency ultrasound devices since this usage will give both therapeutic and preventive advantages for the affected Lives.
Growing Focus on Preventive Healthcare Driving the Market
The growing emphasis on preventive healthcare serves as a considerable propelling factor towards the wide-scale adoption of low frequency ultrasound technology. Increased attention placed on early detection and monitoring of health conditions ensures that ultrasound devices will serve as an invaluable tool in routine health assessments.
The low-frequency ultrasound, in particular, provides a non-invasive, non-harmful, and low-risk diagnostic and monitoring technique for multiple health complaints before further deterioration of the same.
Low-frequency ultrasound offers one of its many significant advantages in aiding in the early detection of cardiovascular problems, including arterial blockages, muscle injuries, and tissue damage. low-frequency ultrasound can be employed to determine blood flow and variations in the health of the vascular access system.
Identification of such pathologies as atherosclerosis is, therefore, invaluable as it allows for the prevention of major cardiovascular events like strokes or heart attacks. Such a condition is, in fact, useful not only in monitoring soft tissue injuries to provide early intervention for muscle stains, ligament tears, or even swelling in joints to prevent long-term impairment but also to speed up the recovery process.
It being such a non-invasive procedure adds further zest to low frequency ultrasound as applicable for preventive care, not utilizing any form of radiation exposure or surgical interference. Hence, it is an acceptable safe procedure for periodic checks of many at-risk patients of chronic conditions.
Further, in line with the heightened trend toward holistic and preventive health management, the ultrasound now being continually adopted by the caregivers into their practices for diagnosis or monitoring offers a proactive route toward health.
Low-frequency ultrasound presents a unique opportunity for the development of advanced drug delivery systems
Low-frequency ultrasound can provide an excellent opportunity for the development of advanced drug delivery systems. Concerning its ability to enhance the permeability of the membranes of the cells, it provides localized and targeted drug delivery and offers marked advantages for conditions such as cancer, chronic conditions, and musculoskeletal injuries.
This technology is non-invasive and thus allows for a more effective delivery of drugs to the various affected tissues while minimizing systemic effects and thus improving the outcome of treatment.
The integration of low-frequency ultrasound with drug delivery platforms opens the doors for precision medicine. For example, the drug given to the cancer patient can be delivered directly to the tumor site, thereby enhancing the effect of chemotherapy while lessening damage to the natural tissue.
Similarly, for musculoskeletal injuries or chronic pain, ultrasound can deliver corticosteroids or analgesics directly to the diseased site, improving the speed of healing and pain control solution.
This opportunity puts low-frequency ultrasound at the quintessence of the new therapeutic ultrasound devices in drug delivery innovation. The ultrasound can be coupled with novel drug formulation or nanoparticles, thereby making it possible to develop targeted therapies with high efficacy.
These and other advances present a significant growth opportunity for the pharmaceutical and healthcare sectors: they promise an augmentation of practice with resultant cost containment for healthcare provision due to the decreased need for invasive procedures or long-term drug therapies and adjuncts.
Competition from Alternative Therapies May Restrict Market Growth
The main restraint hampering growth in the low-frequency ultrasound market is competition from alternative therapies. Various established therapeutic and diagnostic approaches, such as physiotherapy, electromagnetic therapy, and imaging techniques such as MRI and CT scans, can provide similar benefits to low frequency ultrasound thereby maybe sometimes not allowing its open entrance into some fields of medicine.
Physical therapy is widely accepted and is a first-line treatment of choice for many musculoskeletal disorders. Other electromagnetic therapies include TENS and interferential current therapy, which are widely used to manage pain and promote tissue healing and therefore can be considered as therapy alternative to LFU, especially in developing countries where cost is a big issue.
With advances in research and evidence supporting these alternatives, coupled with their usually lower costs and more familiarity among healthcare providers, spread and capture of low-frequency ultrasound in market share remains a challenge.
The global low frequency ultrasound industry recorded a CAGR of 3.1% during the historical period between 2020 and 2024. The growth of low frequency ultrasound industry was positive as it reached a value of USD 2,065.1 million in 2035 from USD 1,239.1 million in 2025.
The advanced global low-frequency ultrasound marketing expanded substantially from 2020 up to 2024 due to technological developments and an increasing enthusiasm for non-invasive, cost-effective treatment. The rise in chronic diseases, an aging population, and a shift toward preventive healthcare drove adoption across therapeutic applications including musculoskeletal disorders, wound care, and pain management.
More portability of the device, better image resolution, and digital platform integration for remote monitoring helped spur growth further.
The subsequently growth of this market is defined by the new trend, to span the time frame from 2025 to 2035. The uptake of low-frequency ultrasound within home healthcare via telemedicine and at-home rehabilitation will present new openings.
The blending of ultrasound with wearable health technology for constant monitoring will further widen its uptake. The industry is expected to be on the rise, while the low-frequency ultrasound to precision medicine and drug delivery totally revolutionize localized therapies potentially for chronic conditions and cancer treatment.
Principal Consultant
Low-frequency ultrasound is mainly led by Tier 1 companies, which control a considerably large share of the market, over 63.2% of the global total, owing to their advanced technology, large-scale R&D investments, and an established presence in the market.
Major players, such as BTL Industries, Bioventus, Orthofix US LLC, and Accelerated Care Plus, provide an extensive array of products and innovative solutions, constituting major motivating forces of the market.
On the second layer lies Tier 2, predominantly some medium-scale, often regionally focused companies, accounting for approximately 21.3% of the market share.
Prominent players include SANUWAVE Health, Inc., Zealmax Innovations Pvt. Ltd that meet certain regional demands and continue innovating for low-frequency ultrasound applications.
Tier 3 companies- Med-Fit UK Ltd, HMS Medical Systems and Others hold around 15.5% of the market. Although their market share is lower, they are nonetheless important enough to be players by providing specialized products and catering to niche market applications.
The section below covers the industry analysis for the low frequency ultrasound market for different countries. Market demand analysis on key countries in several regions of the globe, including North America, Asia Pacific, Europe, and others, is provided.
The United States is anticipated to remain at the forefront in North America, with a CAGR of 2.0% through 2035. In Asia Pacific, China is projected to witness a CAGR of 6.4% by 2035.
| Country | Value CAGR (2025 to 2035) |
|---|---|
| United States | 2.0% |
| Germany | 2.6% |
| France | 3.3% |
| UK | 2.3% |
| China | 6.4% |
| India | 7.3% |
Germany should continue to be the leading market for the low-frequency ultrasound market within Europe, with an expected revenue growth of 2.6% CAGR between 2025 and 2035. Fueled by a robust healthcare system and a commitment to medical innovation, the prospects for further development are unsurpassed.
Germany is known to conduct with a systematic and resourceful healthcare system, making capital investments in medical equipment fully justified by consequent advanced diagnostics and therapeutic options. This has led to a lucrative appeal for low-frequency ultrasound machines in noninvasive treatments in wound care, musculoskeletal disorders, and pain management. All these factors will foster the steady growth of the low-frequency ultrasound market in Germany.
The USA low-frequency ultrasound market is projected to grow at a CAGR of 2.0% during the forecast period, representing the relative maturity of the market even while it maintains overwhelming dominance in North America. The country has long been a leader in ultrasonic technology adoption in a multitude of different medical specialties, notably for diagnostic and therapeutic purposes.
This slow growth can be attributed to the already saturated market where ultrasound devices have become standard in health practices and thus face stiff competition from other imaging modalities such as MRI and CT scan.
The more specific areas for which growth in the USA would most likely come from include drug delivery, pain management, and musculoskeletal imaging. Telemedicine and home healthcare, where ultrasound technology is being applied for remote monitoring and diagnostics, will stimulate some demand while the growth is to be sluggish.
India's low-frequency ultrasound market is hugely growing and expected to lead in the East Asia market with the highest compound annual growth rate of 7.3% between 2025 and 2035. Factors driving much of this growth include an ever-increasing penetration of health services, especially in rural areas, and a large and growing population that further adds to the muscle of demand for alternatives such as low-frequency ultrasound, which is less invasive and less costly.
The emphasis on cost-based healthcare favors both urban and rural adoption in India. It is also boosted by government activities directed at healthcare infrastructure improvement and making available medical technologies. This group of factors assures India’s strong position in the East Asia low-frequency ultrasound market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The section contains information about the leading segments in the industry. Based on product, Portable/ Handheld Devices are expected to account for 62.1% of the global market share in 2025.
| Product | Portable/ Handheld Devices |
|---|---|
| Value Share (2025) | 62.1% |
The therapeutic segment holds the biggest share of the market, as low-frequency ultrasound finds wide applications in pain management, tissue healing, and musculoskeletal disorder treatments. Its non-invasive nature and efficiency in promoting circulation and healing drive high adoption in therapeutic settings, especially in physiotherapy and rehabilitation.
| End User | Hospitals |
|---|---|
| Value Share (2025) | 52.1% |
Hospitals remain the main end-user segment for low-frequency ultrasound devices, thus making up the majority of the market share. The main reason for this is that healthcare infrastructure in hospitals is very advanced, the patient numbers are higher, and ultrasound technologies are used to treat a wide range of diseases. Low-frequency ultrasound is utilized in hospitals, both in diagnostic imaging and therapeutic treatments across a wide range of specializations.
Apart from that, hospitals excel with the ability to add the most advanced ultrasound features like high-resolution imaging and multimodality that help to make precise diagnoses and successful treatment possible.
Moreover, hospitals’ capability of incorporating ultrasound devices into comprehensive patient care processes-such as utilizing imagery during real-time surgeries and post-surgery recovery-gives them an unrivaled market leadership position.
The low-frequency ultrasound market is highly competitive, with key players focusing on innovation and advanced technologies. Companies are investing in R&D, forming strategic partnerships, and pursuing mergers and acquisitions to expand product portfolios and geographical presence. These strategies enable them to cater to diverse healthcare needs and maintain a strong position in the market.
Recent Industry Developments in Low Frequency Ultrasound Market
In terms of product, the industry is divided into into portable/ handheld devices, standalone ultrasound systems and accessories.
In terms of technology, the industry is divided into into continuous wave ultrasound and pulsed wave ultrasound.
In terms of application, the industry is divided into Wound Care, Bone healing, Pain Management, Soft tissue regeneration, Cancer Treatment and Others
In terms of end user, the industry is divided into hospitals, ambulatory surgical centers, Speciality clinics and homecare settings
Key countries of North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, Middle East and Africa (MEA) have been covered in the report.
The global low frequency ultrasound industry is projected to witness CAGR of 5.2% between 2025 and 2035.
The global low frequency ultrasound industry stood at USD 1,184.6 million in 2024.
The global low frequency ultrasound industry is anticipated to reach USD 2,065.1 million by 2035 end.
France is expected to show a CAGR of 3.3% in the assessment period.
The key players operating in the global low frequency ultrasound industry include BTL Industries, SANUWAVE Health, Inc., Zealmax Innovations Pvt. Ltd., Bioventus, Orthofix US LLC, Med-Fit UK Ltd, HMS Medical Systems and Accelerated Care Plus
Explore Healthcare Insights
View Reports
Low Frequency Ultrasound Market
